Enhanced Airway Inflammation and Remodeling in Adenosine Deaminase-Deficient Mice Lacking the A2B Adenosine Receptor

被引:47
|
作者
Zhou, Yang [1 ]
Mohsenin, Amir [1 ]
Morschl, Eva [1 ]
Young, Hays W. J. [1 ]
Molina, Jose G. [1 ]
Ma, Wenbin [2 ]
Sun, Chun-Xiao [1 ]
Martinez-Valdez, Hector [2 ]
Blackburn, Michael R. [1 ]
机构
[1] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA
来源
JOURNAL OF IMMUNOLOGY | 2009年 / 182卷 / 12期
基金
美国国家卫生研究院;
关键词
OBSTRUCTIVE PULMONARY-DISEASE; HUMAN MAST-CELLS; PROINFLAMMATORY CYTOKINES; NEUTROPHIL ELASTASE; MUCIN PRODUCTION; MURINE COLITIS; GENE ABLATION; LUNG INJURY; FIBROSIS; ASTHMA;
D O I
10.4049/jimmunol.0900515
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adenosine is a signaling nucleoside that is generated in response to cellular injury and orchestrates the balance between tissue protection and the progression to pathological tissue remodeling. Adenosine deaminase (ADA)-deficient mice develop progressive airway inflammation and remodeling in association with adenosine elevations, suggesting that adenosine can promote features of chronic lung disease. Furthermore, pharmacological studies in ADA-deficient mice demonstrate that A(2B)R antagonism can attenuate features of chronic lung disease, implicating this receptor in the progression of chronic lung disease. This study examines the contribution of A(2B)R signaling in this model by generating ADA/A(2B)R double-knockout mice. Our hypothesis was that genetic removal of the A(2B)R from ADA-deficient mice would lead to diminished pulmonary inflammation and damage. Unexpectedly, ADA/A(2B)R double-knockout mice exhibited enhanced pulmonary inflammation and airway destruction. Marked loss of pulmonary barrier function and excessive airway neutrophilia are thought to contribute to the enhanced tissue damage observed. These findings support an important protective role for A(2B)R signaling during acute stages of lung disease. The Journal of Immunology, 2009, 182: 8037-8046.
引用
收藏
页码:8037 / 8046
页数:10
相关论文
共 50 条
  • [31] Adenosine Deaminase-Deficient Severe Combined Immunodeficiency and Diffuse Large B-Cell Lymphoma
    Genel, Ferah
    Ozbek, Erhan
    Ozek, Gulcihan
    Vergin, Canan
    Ortac, Ragip
    Santisteban, Ines
    Hershfield, Michael
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2015, 28 (02) : 138 - 142
  • [32] The resurgence of A2B adenosine receptor signaling
    Aherne, Carol M.
    Kewley, Emily M.
    Eltzschig, Holger K.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2011, 1808 (05): : 1329 - 1339
  • [33] Irreversible Antagonists for the Adenosine A2B Receptor
    Temirak, Ahmed
    Schlegel, Jonathan G.
    Voss, Jan H.
    Vaassen, Victoria J.
    Vielmuth, Christin
    Claff, Tobias
    Mueller, Christa E.
    MOLECULES, 2022, 27 (12):
  • [34] Ligands for A2B adenosine receptor subtype
    Baraldi, Pier Giovanni
    Romagnoli, Romeo
    Preti, Delia
    Fruttarolo, Francesca
    Carrion, Maria Dora
    Tabrizi, Mojgan Aghazadeh
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (28) : 3467 - 3482
  • [35] Prodrugs of A2B adenosine receptor antagonists
    Kalla, Rao
    Elzein, Elfatih
    Koltun, Dmitry
    Li, Xiaofen
    Perry, Thao
    Parkhill, Eric
    Zeng, Dewan
    Fong, Irving
    Leung, Kwan
    Zablocki, Jeff
    PURINERGIC SIGNALLING, 2008, 4 : S21 - S22
  • [36] The A2B adenosine receptor protects against inflammation and excessive vascular adhesion
    Yang, Dan
    Zhang, Ying
    Nguyen, Hao G.
    Koupenova, Milka
    Chauhan, Anil K.
    Makitalo, Maria
    Jones, Matthew R.
    Hilaire, Cynthia St.
    Seldin, David C.
    Toselli, Paul
    Larnperti, Edward
    Schreiber, Barbara M.
    Gavras, Haralambos
    Wagner, Denisa D.
    Ravid, Katya
    JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (07): : 1913 - 1923
  • [37] Evidence for the role of A2B adenosine receptor in the regulation of vascular tone using A2B KO mice
    Sanjani, Maryam Sharifi
    Ponnoth, Dovenia
    Roush, Kevin
    Tilley, Stephen
    Mustafa, S. Jamal
    FASEB JOURNAL, 2010, 24
  • [38] Clinical targets of A2B adenosine receptor antagonists
    Linden, J
    Figler, RA
    Jacobson, KA
    Wang, GQ
    LaNoue, KF
    DRUG DEVELOPMENT RESEARCH, 2002, 56 (04) : 556 - 556
  • [39] The role of the A2B adenosine receptor in pulmonary fibrosis
    Blackburn, Michael
    Pedroza, Mesias
    PURINERGIC SIGNALLING, 2010, 6 : 32 - 32
  • [40] A2B adenosine receptor antagonists and their potential indications
    Zablocki, Jeff
    Elzein, Elfatih
    Kalla, Rao
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (10) : 1347 - 1357